文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

静脉-静脉体外膜氧合期间早期重新应用俯卧位治疗急性呼吸窘迫综合征:一项前瞻性观察研究及倾向性匹配分析

Early reapplication of prone position during venovenous ECMO for acute respiratory distress syndrome: a prospective observational study and propensity-matched analysis.
PubMed 文献 · Ann Intensive Care · 2024-08-20
一句话结论严重ARDS患者在VV-ECMO前已接受俯卧位者,ECMO支持后继续俯卧位可能提高成功脱离VV-ECMO的概率(倾向性匹配后64.4% vs 42.2%,P=0.035)。

这项前瞻性观察研究纳入165例接受VV-ECMO的严重ARDS患者,按ECMO期间是否早期联合俯卧位分为俯卧位组50例和仰卧位组115例。俯卧位期间动脉血氧分压显著升高而呼吸机或ECMO设置未变,潮气阻抗显著向背侧区域转移,肺超声评分在前区和后区均显著降低。倾向性匹配后每组45例,俯卧位组成功脱离VV-ECMO比例更高(64.4% vs 42.2%,P=0.035),60天死亡率更低(37.8% vs 60.0%,P=0.035)。作者结论认为VV-ECMO前已接受俯卧位的严重ARDS患者应在ECMO支持后继续俯卧位。

要点

  • 倾向性匹配后每组45例,俯卧位组成功脱离VV-ECMO比例64.4% vs 仰卧位组42.2%(P=0.035)。
  • 倾向性匹配后俯卧位组60天死亡率37.8% vs 仰卧位组60.0%(P=0.035)。
  • 匹配前俯卧位组成功脱离ECMO 32例(64%)、仰卧位组61例(53%),俯卧位组 tended to be higher but not statistically significant。
  • 俯卧位期间动脉血氧分压显著升高,呼吸机和ECMO设置未变;潮气阻抗显著向背侧区域转移,肺超声评分前区和后区均显著降低。
  • 作者结论:VV-ECMO前已接受俯卧位的严重ARDS患者应在VV-ECMO支持后继续俯卧位,该策略可能提高成功脱离VV-ECMO的概率。

适用人群与场景

  • 接受VV-ECMO治疗的严重ARDS患者,且VV-ECMO前已接受俯卧位。
  • 研究纳入165例患者,俯卧位组50例、仰卧位组115例;倾向性匹配后每组45例。

研究设计与关键结果

  • 研究类型为前瞻性观察研究,纳入165例接受VV-ECMO的严重ARDS患者,按ECMO期间是否早期联合俯卧位分为俯卧位组(50例)和仰卧位组(115例)。
  • 匹配前俯卧位组32例(64%)、仰卧位组61例(53%)成功脱离ECMO,俯卧位组 tended to be higher but not statistically significant。
  • 俯卧位期间动脉血氧分压显著升高,呼吸机或ECMO设置未变;潮气阻抗显著向背侧区域转移,肺超声评分前区和后区均显著降低。
  • 倾向性匹配后每组45例,俯卧位组成功脱离VV-ECMO比例64.4% vs 仰卧位组42.2%(P=0.035)。
  • 倾向性匹配后俯卧位组60天死亡率37.8% vs 仰卧位组60.0%(P=0.035)。

证据类型、等级与局限

  • 证据类型:前瞻性观察研究及倾向性匹配分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者结论认为,VV-ECMO前已接受俯卧位的严重ARDS患者应在VV-ECMO支持后继续俯卧位,该策略可能提高成功脱离VV-ECMO的概率。

指南或共识出处

  • 研究注册于ClinicalTrials.Gov:NCT04139733,注册日期2019年10月23日。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: A combination of prone positioning (PP) and venovenous extracorporeal membrane oxygenation (VV-ECMO) is safe, feasible, and associated with potentially improved survival for severe acute respiratory distress syndrome (ARDS). However, whether ARDS patients, especially non-COVID-19 patients, placed in PP before VV-ECMO should continue PP after a VV-ECMO connection is unknown. This study aimed to test the hypothesis that early use of PP during VV-ECMO could increase the proportion of patients successfully weaned from ECMO support in severe ARDS patients who received PP before ECMO.

METHODS: In this prospective observational study, patients with severe ARDS who were treated with VV-ECMO were divided into two groups: the prone group and the supine group, based on whether early PP was combined with VV-ECMO. The proportion of patients successfully weaned from VV-ECMO and 60-day mortality were analyzed before and after propensity score matching.

RESULTS: A total of 165 patients were enrolled, 50 in the prone and 115 in the supine group. Thirty-two (64%) and 61 (53%) patients were successfully weaned from ECMO in the prone and the supine groups, respectively. The proportion of patients successfully weaned from VV-ECMO in the prone group tended to be higher, albeit not statistically significant. During PP, there was a significant increase in partial pressure of arterial oxygen (PaO2) without a change in ventilator or ECMO settings. Tidal impedance shifted significantly to the dorsal region, and lung ultrasound scores significantly decreased in the anterior and posterior regions. Forty-five propensity score-matched patients were included in each group. In this matched sample, the prone group had a higher proportion of patients successfully weaned from VV-ECMO (64.4% vs. 42.2%; P = 0.035) and lower 60-day mortality (37.8% vs. 60.0%; P = 0.035).

CONCLUSIONS: Patients with severe ARDS placed in PP before VV-ECMO should continue PP after VV-ECMO support. This approach could increase the probability of successful weaning from VV-ECMO.

TRIAL REGISTRATION: ClinicalTrials.Gov: NCT04139733. Registered 23 October 2019.

来源:Ann Intensive Care,查看原文。版权归原作者所有。

参考来源

  1. Wang R, Tang X, Li X, et al. Early reapplication of prone position during venovenous ECMO for acute respiratory distress syndrome: a prospective observational study and propensity-matched analysis. Ann Intensive Care. 2024. PMID: 39162882. doi:10.1186/s13613-024-01365-4

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。